A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, colorectal cancers and advanced NSCLC, limiting access to biomarker-driven ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Prostate Cancer is the second leading cause of death in American men after lung cancer. In 2018, 165,000 men will be diagnosed with prostate cancer. The question all men with prostate cancer need ...

BALTIMORE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...

New Australian research has highlighted the urgent need for a national framework to guide genetic testing for prostate cancer, with experts warning ...

Impact of a diagnostic bronchoscopy service with embedded reflex molecular testing within an oncology centre in patients with lung cancer: The Bronchiomics study. This is an ASCO Meeting Abstract from ...